Published in AIDS Behav on May 01, 2014
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS Care (2014) 0.87
A temperature-monitoring vaginal ring for measuring adherence. PLoS One (2015) 0.86
Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women. PLoS One (2015) 0.78
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Assessing sexual risk behaviour with the Timeline Followback (TLFB) approach: continued development and psychometric evaluation with psychiatric outpatients. Int J STD AIDS (2001) 3.66
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS Behav (2013) 2.03
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet (2009) 6.96
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet (2011) 6.91
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials (2007) 4.93
Non-publication of large randomized clinical trials: cross sectional analysis. BMJ (2013) 4.91
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol (2004) 3.28
Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med (2009) 3.18
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr (2007) 2.67
Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog (2008) 2.59
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis (2012) 2.42
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis (2004) 2.29
Antiretroviral prophylaxis: a defining moment in HIV control. Lancet (2011) 2.17
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One (2008) 2.09
Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression. AIDS (2013) 2.04
Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS (2003) 1.95
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS (2010) 1.94
Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa. PLoS Med (2006) 1.90
A model designed to enhance informed consent: experiences from the HIV prevention trials network. Am J Public Health (2005) 1.89
AIDS research must link to local policy. Nature (2010) 1.81
Monitoring and assessment of wetlands using Earth Observation: the GlobWetland project. J Environ Manage (2008) 1.74
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res Hum Retroviruses (2003) 1.68
Effect of an emergency contraceptive pill intervention on pregnancy risk behavior. Contraception (2008) 1.68
Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav (2010) 1.60
Patients' readiness to start highly active antiretroviral treatment for HIV. BMJ (2005) 1.54
Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base. BJU Int (2014) 1.54
The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr (2005) 1.51
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol (2004) 1.50
Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol (2009) 1.49
Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr (2010) 1.49
Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clin Vaccine Immunol (2011) 1.47
Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr (2012) 1.43
High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr (2002) 1.43
Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis (2008) 1.42
A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J Acquir Immune Defic Syndr (2004) 1.42
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr (2014) 1.36
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa. J Acquir Immune Defic Syndr (2011) 1.31
Practice brief: adolescents and HIV clinical trials: ethics, culture, and context. J Assoc Nurses AIDS Care (2007) 1.29
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception (2012) 1.27
Patterns of distress in African-American mothers of preterm infants. J Dev Behav Pediatr (2009) 1.26
Multilevel and kin selection in a connected world. Nature (2010) 1.26
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One (2013) 1.24
Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol (2004) 1.24
Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis (2009) 1.21
HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS (2009) 1.18
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol (2011) 1.13
High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. S Afr Med J (2007) 1.09
Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis (2010) 1.09
Utilizing nucleic acid amplification to identify acute HIV infection. AIDS (2007) 1.07
Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis. Syst Rev (2014) 1.06
Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS Res Hum Retroviruses (2007) 1.06
Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol (2010) 1.04
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses (2005) 1.03
Ethics guidance for HIV prevention trials. BMJ (2003) 1.03
Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS Behav (2014) 1.00
Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. Ann Epidemiol (2011) 1.00
CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. J Infect Dis (2012) 0.99
Infant feeding options, other nonchemoprophylactic factors, and mother-to-child transmission of HIV in Zambia. J Int Assoc Physicians AIDS Care (Chic) (2011) 0.98
Anaemia in acute HIV-1 subtype C infection. PLoS One (2008) 0.96
Changes in Natural Killer cell activation and function during primary HIV-1 Infection. PLoS One (2013) 0.96
Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data. AIDS Behav (2010) 0.95
The impact of price changes on demand for family planning and reproductive health services in Ecuador. Health Policy Plan (2002) 0.94
An exploration of the relationship between youth assets and engagement in risky sexual behaviors. J Adolesc Health (2004) 0.94
Shared decision-making in the selection of outpatient analgesics for older individuals in the emergency department. J Am Geriatr Soc (2013) 0.94
Ethical challenges in international HIV prevention research. Account Res (2004) 0.94
Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antivir Ther (2012) 0.94
Knowledge and acceptability of HAART among TB patients in Durban, South Africa. AIDS Care (2005) 0.93
Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing. PLoS One (2013) 0.92
Topical microbicides--what's new? J Acquir Immune Defic Syndr (2013) 0.92
Engaging key stakeholders to assess and improve the professional preparation of MPH health educators. Am J Public Health (2010) 0.90
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines. Vaccine (2013) 0.90
Agronomic and environmental implications of enhanced s-triazine degradation. Pest Manag Sci (2010) 0.90
Time for gender mainstreaming in editorial policies. J Int AIDS Soc (2011) 0.89
Disclosure of HIV status: Experiences of Patients Enrolled in an Integrated TB and HAART Pilot Programme in South Africa. Afr J AIDS Res (2009) 0.88
Sustainability of task-shifting for antiretroviral treatment. Lancet (2012) 0.87
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS Care (2014) 0.87
No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. PLoS One (2013) 0.86
Decreased condom breakage and slippage rates after counseling men at a sexually transmitted infection clinic in Jamaica. Contraception (2007) 0.86
HIV infection in high school students in rural South Africa: role of transmissions among students. AIDS Res Hum Retroviruses (2014) 0.86
Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting. AIDS Behav (2015) 0.85
Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents (2005) 0.85
Service delivery characteristics associated with contraceptive use among youth clients in integrated voluntary counseling and HIV testing clinics in Kenya. AIDS Care (2012) 0.85
Perceptions of dry eye disease management in current clinical practice. Eye Contact Lens (2014) 0.85
Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier. AIDS Res Hum Retroviruses (2011) 0.85
Antiretroviral prophylaxis for HIV prevention reaches a key milestone. Lancet (2012) 0.85
Initiating antiretrovirals during tuberculosis treatment: a drug safety review. Expert Opin Drug Saf (2011) 0.85
Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid. BMC Public Health (2010) 0.85
Identification of genetic defects in the atoxigenic biocontrol strain Aspergillus flavus K49 reveals the presence of a competitive recombinant group in field populations. Int J Food Microbiol (2012) 0.84
Critical next steps for female condom research--report from a workshop. Contraception (2009) 0.84